These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 22043860)
1. Effect of oestradiol and pathogen-associated molecular patterns on class II-mediated antigen presentation and immunomodulatory molecule expression in the mouse female reproductive tract. Ochiel DO; Rossoll RM; Schaefer TM; Wira CR Immunology; 2012 Jan; 135(1):51-62. PubMed ID: 22043860 [TBL] [Abstract][Full Text] [Related]
2. Polarized uterine epithelial cells preferentially present antigen at the basolateral surface: role of stromal cells in regulating class II-mediated epithelial cell antigen presentation. Wira CR; Rossoll RM; Young RC J Immunol; 2005 Aug; 175(3):1795-804. PubMed ID: 16034121 [TBL] [Abstract][Full Text] [Related]
3. Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-beta production by epithelial cells in mediating antigen-presenting cell function. Wira CR; Rossoll RM Immunology; 2003 Jul; 109(3):398-406. PubMed ID: 12807486 [TBL] [Abstract][Full Text] [Related]
4. Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells. Wira CR; Rossoll RM; Kaushic C Endocrinology; 2000 Aug; 141(8):2877-85. PubMed ID: 10919275 [TBL] [Abstract][Full Text] [Related]
5. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Wira CR; Rossoll RM Immunology; 1995 Apr; 84(4):505-8. PubMed ID: 7790022 [TBL] [Abstract][Full Text] [Related]
6. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Pan J; Ju D; Wang Q; Zhang M; Xia D; Zhang L; Yu H; Cao X Immunol Lett; 2001 Apr; 76(3):153-61. PubMed ID: 11306142 [TBL] [Abstract][Full Text] [Related]
7. Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract. Kaushic C; Frauendorf E; Rossoll RM; Richardson JM; Wira CR Am J Reprod Immunol; 1998 Mar; 39(3):209-16. PubMed ID: 9526610 [TBL] [Abstract][Full Text] [Related]
8. Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils. Tamura N; Ishii N; Nakazawa M; Nagoya M; Yoshinari M; Amano T; Nakazima H; Minami M Scand J Immunol; 1996 Sep; 44(3):229-38. PubMed ID: 8795716 [TBL] [Abstract][Full Text] [Related]
9. Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Wira CR; Rossoll RM Endocrinology; 1995 Oct; 136(10):4526-34. PubMed ID: 7664673 [TBL] [Abstract][Full Text] [Related]
10. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. Askew D; Chu RS; Krieg AM; Harding CV J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813 [TBL] [Abstract][Full Text] [Related]
11. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation. McLellan AD; Heiser A; Hart DN Immunology; 1999 Oct; 98(2):171-80. PubMed ID: 10540215 [TBL] [Abstract][Full Text] [Related]
12. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation. Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379 [TBL] [Abstract][Full Text] [Related]
13. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. Prabhala RH; Wira CR J Immunol; 1995 Dec; 155(12):5566-73. PubMed ID: 7499839 [TBL] [Abstract][Full Text] [Related]
14. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation. Clatza A; Bonifaz LC; Vignali DA; Moreno J J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847 [TBL] [Abstract][Full Text] [Related]
15. Virosome-mediated delivery of protein antigens to dendritic cells. Bungener L; Serre K; Bijl L; Leserman L; Wilschut J; Daemen T; Machy P Vaccine; 2002 May; 20(17-18):2287-95. PubMed ID: 12009284 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen. Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790 [TBL] [Abstract][Full Text] [Related]
17. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse. Soboll G; Schaefer TM; Wira CR Am J Reprod Immunol; 2006 Jun; 55(6):434-46. PubMed ID: 16674601 [TBL] [Abstract][Full Text] [Related]
18. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. George-Chandy A; Eriksson K; Lebens M; Nordström I; Schön E; Holmgren J Infect Immun; 2001 Sep; 69(9):5716-25. PubMed ID: 11500448 [TBL] [Abstract][Full Text] [Related]
20. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells. Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]